Mirtazapine (Remeron) may rarely cause a serious blood disorder called agranulocytosis. If fever, sore throat, or other signs of infection develop while on mirtazapine, and white blood cell counts are elevated, the medication should be discontinued. Mirtazapine may cause an increase in appetite and weight gain. It may also cause drowsiness and/or dizziness. And it can increase cholesterol and triglyceride levels as well as affect liver enzyme levels.Mobic 15mg
Holiday Depression and Stress Use Fexofenadine-D with caution if you have high blood pressure, diabetes, heart disease, increased pressure in the eyes, prostate problems, or hyperthyroidism. S using it and check with your doctor if it causes nervousness, dizziness, or sleeplessness.
muscle acheslack of menstrual periods, Directions:Viagra Capsules 50mg
Each mL of COMBIGAN contains the active ingredients brimonidine tartrate 0.2% and timolol 0.5% with the inactive ingredients benzalkonium chloride 0.005%; sodium phosphate, monobasic; sodium phosphate, dibasic; purified water; and hydrochloric acid and/or sodium hydroxide to adjust pH.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.Buy Cozaar 100mg
Very common (10% or more): Pain (included flank and back pain; up to 13%)LAMICTAL can cause serious rashes requiring hospitalization and discontinuation of treatment. The incidence of these rashes, which have included Stevens-Johnson syndrome, is approximately 0.8% (8 per 1,000) in pediatric patients (aged 2 to 16 years) receiving LAMICTAL as adjunctive therapy for epilepsy and 0.3% (3 per 1,000) in adults on adjunctive therapy for epilepsy. In clinical trials of bipolar and other mood disorders, the rate of serious rash was 0.08% (0.8 per 1,000) in adult patients receiving LAMICTAL as initial monotherapy and 0.13% (1.3 per 1,000) in adult patients receiving LAMICTAL as adjunctive therapy. In a prospectively followed cohort of 1,983 pediatric patients (aged 2 to 16 years) with epilepsy taking adjunctive LAMICTAL, there was 1 rash-related death. In worldwide postmarketing experience, rare cases of toxic epidermal necrolysis and/or rash-related death have been reported in adult and pediatric patients, but their numbers are too few to permit a precise estimate of the rate.Serotonin-norepinephrine reuptake inhibitors (SNRIs)Prev page:Cheap Azulfidine 500mg